US Patent 9815817 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Patent 9815817 was granted and assigned to FORMA Therapeutics on November, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 18, 2015
Date of Patent
November 14, 2017
Patent Applicant
Patent Application Number
14858165
Patent Citations Received
Patent Inventor Names
Anna Ericsson
0
Ann-Marie Campbell
0
Susan Ashwell
0
Wei Lu
0
Zhongguo Wang
0
David R. Lancia, Jr.
0
Gary Gustafson
0
Jian Lin
0
Justin Andrew Caravella
0
R Bruce Diebold
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9815817 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
